Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.3 HKD | +2.10% | +7.20% | +9.28% |
04-15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
04-15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.28% | 635M | |
+26.08% | 662B | |
+22.17% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 289B | |
+13.68% | 234B | |
+4.14% | 198B | |
-11.08% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- 1477 Stock
- News Ocumension Therapeutics
- Ocumension Therapeutics : Controlling Shareholders Cut Stake in Firm; Shares Jump 6%